Bortenat 3.5 – Multiple Myeloma Treatment

oncology  /  Bortenat 3.5

Bortenat 3.5

Bortenat is a medication based on bortezomib used to treat multiple myeloma and certain types of lymphoma. The drug inhibits proteasomes, leading to cancer cell death and slowing disease progression.... Bortenat is a medication based on bortezomib used to treat multiple myeloma and certain types of lymphoma. The drug inhibits proteasomes, leading to cancer cell death and slowing disease progression. Bortenat can be used alone or in combination with other medicines. It is administered intravenously or subcutaneously according to the prescribed regimen. Side effects may occur, so medical supervision is necessary. Read more Hide

• Active ingredient:
  Bortezomib
• Manufacturer: Natco
• Dosage: 4 mg
• Dosage form: Vial
• Units per pack: 1
• Delivery across Ukraine
• 100% original product